Navigation Links
Processed Tomato Products May Protect Against Inflammation, According to a Study Presented at the Experimental Biology Meeting

SACRAMENTO, Calif., April 21 /PRNewswire-USNewswire/ -- Tomato products may protect against inflammation. Such were the findings from a recent multi-center, randomized, controlled trial on the effects of processed tomatoes on vasodilatation and C-reactive protein in overweight and obese men and women, presented by one of the study researchers, Rose M Giordano, Ph.D. on April 19, 2009 at the Experimental Biology meeting held in New Orleans, La.


An immerging body of research suggests that inflammation may be a significant component in the development of chronic diseases such as cardiovascular disease, cancer, obesity, metabolic syndrome, type 2 diabetes, osteoporosis, periodontal disease, rheumatoid arthritis, neurological degenerative disorders, and inflammatory bowel disorders. There is growing interest in the role that diet may play in reducing inflammation in order to protect against such chronic diseases.

The regular consumption of tomato products has been consistently associated with a lower risk of several types of cancer and coronary heart disease. Using data from adults in the National Health and Nutrition Examination Survey (1999-2004), researchers recently found that consumption of processed tomatoes was associated with significantly lower serum C-reactive protein. C-reactive protein is a recognized biomarker of inflammation.

Scientists are intrigued with the array of nutrients such as vitamins A and C, fiber, potassium, beta-carotene, and lycopene that appear to work together in unison to provide health benefits. Particular interest has surrounded lycopene, a powerful antioxidant found abundantly in processed tomato products. Tomatoes, the second most popular vegetable in the country, represent an excellent opportunity to ward off chronic disease. Since processed tomato products are both economical and easily adaptable to a variety of cultural diets, their health benefits warrant further investigation.

Given the potential for tomato products to protect against chronic disease, researchers from the University of California, Davis, National Center for Food Safety & Technology in Illinois, and Penn State University investigated the effects of processed tomato products on vasodilatation (another target for lowering disease through dietary strategies) and C-reactive protein on overweight and obese men and women. Within the diets of 56 free-living individuals participating in the study, processed tomato products or non-tomato products were matched in calories, sodium, and sugar content. All of the test subjects consumed a low-tomato diet for three weeks followed by either a six week high-tomato diet or low-tomato diet. At six weeks, the subjects were assessed as to the response of tomato after eating a high-fat meal. Compared with the low-tomato group, the high-tomato group experienced a C-reactive protein level that was lower in response to the high-fat meal. High-tomato intake was also associated with increased mean vessel diameter, but flow mediated vasodilatation was not different, possibly related to the BMI of subjects. The researchers concluded that processed tomatoes provide a protective role on inflammation, but increasing adiposity may negate the benefits of the high-tomato diet on endothelial function.

Researchers in the study include Rose M Giordano, Tissa Kappagoda, Mandeep Cheema, Jack Cappozzo, Yumei Cao, Penny Kris-Etherton, and Britt Burton-Freeman. The study was sponsored by the Tomato Products Wellness Council (

If you would like additional information or would like to schedule an interview, please contact Rodger Wasson at (831) 254-5405 or

    Rodger Wasson
    Telephone: (831) 254-5405

SOURCE Tomato Products Wellness Council
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. MultiCell Technologies Signs Liver Stem Cell R&D Agreement To Develop Products for the Study of Liver Cancer
2. Evidence Lacking in Multivitamin Study of Womens Risk of Cancer, Heart Disease or Death, Says Natural Products Association
3. IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP)
4. Clinical Lab Products Magazine Features Biomoda
5. IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP)
6. Nephros Completes Pivotal U.S. Clinical Trial for its Hemodiafiltration Products
7. CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model
8. Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743
9. Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives
10. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
11. TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis
Post Your Comments:
(Date:6/24/2016)... CLEMENTE, Calif. , June 24, 2016  American Respiratory Labs ... company, is now able to perform sophisticated lung assessments in patients, ... Technologies , Inc. Patients are no longer limited ... ndd,s EasyOne PRO ® , ARL patients like Jeanne R. of ... done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... HOUSTON , June 23, 2016  MedSource ... platform as its e-clinical software solution of choice.  ... the best possible value to their clients by ... nowEDC.  The preferred relationship establishes nowEDC as the ... pricing for MedSource,s full-service clients.  "nowEDC has long ...
Breaking Medicine Technology:
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
Breaking Medicine News(10 mins):